Government
TAP officials acquitted in Lupron case in Boston
NEWS IN BRIEF — Posted Aug. 2, 2004
After a three-month trial, a federal jury in Boston acquitted eight TAP Pharmaceutical Products Inc. employees of charges that they offered kickbacks to physicians to prescribe its prostate cancer drug Lupron. The current and former employees were accused of offering doctors trips and other incentives to persuade them to prescribe the TAP drug instead of competitors' products.
The trial was part of a larger probe of the company. In October 2001, TAP Pharmaceutical agreed to pay $875 million to resolve civil and criminal charges related to its pricing and marketing of Lupron.
Note: This item originally appeared at http://www.ama-assn.org/amednews/2004/08/02/gvbf0802.htm.












